Relation of season and temperature to endothelium-dependent flow-mediated vasodilation in subjects without clinical evidence of cardiovascular disease (from the Framingham heart study)

被引:73
|
作者
Widlansky, Michael E.
Vita, Joseph A.
Keyes, Michelle J.
Larson, Martin G.
Hamburg, Naomi M.
Levy, Daniel
Mitchell, Gary F.
Osypiuk, Ewa W.
Vasan, Ramachandran S.
Benjamin, Emelia J. [1 ]
机构
[1] Boston Univ, Sch Med, Dept Cardiol, Boston, MA 02215 USA
[2] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02215 USA
[3] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02215 USA
[4] Boston Univ, Sch Publ Hlth, Dept Math & Stat, Boston, MA 02215 USA
[5] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA
[6] Cardiovasc Engn Inc, Waltham, MA USA
[7] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2007年 / 100卷 / 03期
关键词
D O I
10.1016/j.amjcard.2007.03.055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple studies have documented an increased incidence of cardiovascular events in the winter, but the pathophysiologic mechanisms remain incompletely understood. It was hypothesized that brachial flow and flow-mediated dilation (FMD) would vary by season and temperature. Season and temperature were related to ultrasonic brachial artery endotheliumdependent FMD% (n = 2,587), baseline flow velocity, and maximal reactive hyperemia (n = 1,973) in the Framingham Offspring Cohort (mean age 61 +/- 10 years, 53% women). Outdoor temperatures were obtained from National Climate Data Center records for Bedford, Massa-, chusetts (about 14 miles from the testing site), and the examination room temperature was measured. In multivariate models, FMD% was highest in summer and lowest in winter (3.01 +/- 0.09% vs 2.56 +/- 0.10%, respectively, p = 0.02 for differences across all 4 seasons). FMD% was highest in the warmest and lowest in the coldest outdoor-temperature quartiles. In stepwise models adjusting for risk factors and selecting among season, outdoor temperature, and room temperature, FMD% was associated with season (p = 0.02); temperature did not enter the model. In contrast, hyperemic flow velocity was significantly lower for cooler and higher for warmer room temperatures (p = 0.02 overall); season did not enter the model. Season and outdoor and room temperature were each retained in a stepwise model of baseline flow velocity (p < 0.0001, p = 0.02, and p < 0.0001, respectively). In conclusion, a significant association was observed between season and FMD%. Microvascular vasodilator function, as reflected by hyperemic flow velocity, was more strongly related to temperature than season. Endothelial dysfunction may be 1 of the mechanisms influencing seasonal variation in cardiovascular events. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:518 / 523
页数:6
相关论文
共 17 条
  • [1] Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism
    Nishizaka, MK
    Zaman, MA
    Green, SA
    Renfroe, KY
    Calhoun, DA
    CIRCULATION, 2004, 109 (23) : 2857 - 2861
  • [2] Seasonal variation of endothelium-dependent flow-mediated vasodilation measured in the same subjects
    Iwata, Masako
    Miyashita, Yutaka
    Kumagai, Hiromichi
    AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE, 2012, 2 (02): : 111 - 115
  • [3] Clinical impacts of endothelium-dependent flow-mediated vasodilation assessment on primary aldosteronism
    Watanabe, Daisuke
    Morimoto, Satoshi
    Morishima, Noriko
    Ichihara, Atsuhiro
    ENDOCRINE CONNECTIONS, 2021, 10 (06) : 578 - 587
  • [4] Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease
    Takase, B
    Uehata, A
    Akima, T
    Nagai, T
    Nishioka, T
    Hamabe, A
    Satomura, K
    Ohsuzu, F
    Kurita, A
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (12): : 1535 - +
  • [5] Assessment of flow-mediated endothelium-dependent vasodilation in patients with acute decompensated chronic heart failure treated with anticoagulants
    Shevchenko, I. Irina
    Shavarov, A. A.
    Kiyakbayev, G. K.
    Moiseev, V. S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 417 - 417
  • [6] Impaired flow-mediated endothelium-dependent and endothelium-independent vasodilation of the brachial artery in patients with atherosclerotic peripheral vascular disease
    Komai, Hiroyoshi
    Higami, Yayoi
    Tanaka, Hisaharu
    Honda, Kentaro
    Juri, Masanohu
    Okamura, Yoshitaka
    ANGIOLOGY, 2008, 59 (01) : 52 - 56
  • [7] Flow-mediated vasodilation is not impaired in individuals with a parental history of premature coronary heart disease: The Framingham Heart Study.
    Kathiresan, S
    Larson, MG
    Kupka, MJ
    Mitchell, GF
    Vasan, RS
    Keaney, JF
    Lehman, BT
    Fan, SX
    Osypiuk, E
    Vita, JA
    Benjamin, EJ
    CIRCULATION, 2004, 109 (07) : E123 - E123
  • [8] Acute Type 5 phosphodiesterase inhibition with sildenafil enhances endothelium-dependent, flow-mediated vasodilation in patients with chronic heart failure
    Katz, S
    Balidemaj, K
    Homma, S
    Wu, H
    Maybaum, S
    CIRCULATION, 1999, 100 (18) : 861 - 861
  • [9] Short-term sibutramine therapy improves flow-mediated endothelium-dependent vasodilation of the brachial artery in obese patients with coronary artery disease
    Shechter, M
    Usmanov, V
    Stanislava, G
    Feinberg, MS
    EUROPEAN HEART JOURNAL, 2004, 25 : 96 - 96
  • [10] The association of brachial artery flow-mediated dilation and long-term cardiovascular events in subjects without heart disease
    Shechter, M.
    Shechter, A.
    Koren-Morag, N.
    Hiersch, L.
    EUROPEAN HEART JOURNAL, 2013, 34 : 311 - 311